MedPath

Prednisolone

Generic Name
Prednisolone
Brand Names
Millipred Dp 6 Day
Drug Type
Small Molecule
Chemical Formula
C21H28O5
CAS Number
50-24-8
Unique Ingredient Identifier
9PHQ9Y1OLM
Background

Prednisolone is a glucocorticoid similar to cortisol used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.

Prednisolone was granted FDA approval on 21 June 1955.

Indication

Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Allergic Bronchopulmonary Aspergillosis, Allergic Conjunctivitis (AC), Allergic Contact Dermatitis, Allergic Skin Reaction, Allergic corneal marginal ulcers, Alveolitis, Extrinsic Allergic, Ankylosing Spondylitis (AS), Aspiration Pneumonia, Aspiration Pneumonitis, Atopic Dermatitis, Bell's Palsy, Berylliosis, Bullous dermatitis herpetiformis, Burns, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Corneal injuries, Corneal ulceration, Crohn's Disease (CD), Cyclitis, Dermatomyositis (DM), Dermatosis of the Ear Canal, Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Erythroblastopenia, Exacerbation of COPD, Exacerbation of asthma, Eye inflammation caused by Cataract Surgery, Eye inflammation caused by Infection, Fissure;Anal, Herpes Zoster Keratitis, Hot Water Burns (Scalds), Hypercalcemia of Malignancy, Idiopathic Pulmonary Fibrosis (IPF), Immune Thrombocytopenia (ITP), Inflamed External Hemorrhoid, Inflamed Hemorrhoids, Internal, Inflammatory Reaction caused by susceptible Bacterial Infections, Iridocyclitis, Iritis, Itching caused by susceptible Bacterial Infections, Keratitis, Loeffler's syndrome, Lymphoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Multiple sclerosis exacerbation, Mycosis Fungoides (MF), Ocular Inflammation, Ophthalmia, Sympathetic, Optic Neuritis, Otic Eczema, Pemphigus, Perennial Allergic Rhinitis (PAR), Pericarditis, Pneumocystis Jirovecii Pneumonia, Polymyalgia Rheumatica (PMR), Posterior Uveitis, Posttraumatic Osteoarthritis, Proctitis, Proteinuria, Pruritus, Pruritus Ani, Psoriatic Arthritis, Pulmonary Tuberculosis (TB), Pure Red Cell Aplasia, Rash, Relapsing Polychondritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Seasonal Allergic Rhinitis, Secondary Adrenal Insufficiency, Secondary thrombocytopenia, Serum Sickness, Severe Asthma, Sjogren's Syndrome (SS), Stevens-Johnson Syndrome, Superficial punctate keratitis, Synovitis, Systemic Lupus Erythematosus, Transplanted Organ Rejection, Trichinosis, Tuberculosis (TB), Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Vasculitis, Acquired immune hemolytic anemia, Acute Bursitis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Anal eczema, Bacterial skin infections, Exfoliative erythroderma, Idiopathic Bronchiolitis obliterans with organizing pneumonia, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Primary adrenocoritical insufficiency, Severe Psoriasis, Severe Seborrhoeic dermatitis, Severe alcoholic liver disease, Steroid-responsive inflammation of the eye, Subacute Bursitis, Susceptible Bacterial Infections, Symptomatic Sarcoidosis, Varicella-zoster virus acute retinal necrosis

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis

Phase 3
Not yet recruiting
Conditions
Alcoholic Hepatitis
Interventions
Drug: Placebo of N-acetylcysteine
Drug: Placebo of Prednisolone
First Posted Date
2025-05-04
Last Posted Date
2025-05-04
Lead Sponsor
University Hospital, Lille
Target Recruit Count
477
Registration Number
NCT06956482

Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Patients

Phase 2
Not yet recruiting
Conditions
Crohn Disease
Nutrition Assessment
Diet Therapy
Interventions
Dietary Supplement: aCDED + Modulen
First Posted Date
2025-05-01
Last Posted Date
2025-05-01
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
52
Registration Number
NCT06953791

Comparing Effectiveness of Steroids and Methotrexate in Treatment of Chronic Inflammatory Breast Disease

Phase 4
Not yet recruiting
Conditions
Idiopathic Granulomatous Mastitis
Interventions
First Posted Date
2025-04-24
Last Posted Date
2025-04-24
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
40
Registration Number
NCT06943482
Locations
🇸🇬

National University Hospital, Singapore, Singapore

Short Course Steroids in Alcohol Associated Hepatitis

Phase 3
Recruiting
Conditions
Alcoholic Hepatitis
Interventions
First Posted Date
2025-04-09
Last Posted Date
2025-04-17
Lead Sponsor
Asian Institute of Gastroenterology, India
Target Recruit Count
146
Registration Number
NCT06919458
Locations
🇮🇳

AIG, Hyderabad, Telangana, India

🇮🇳

AIG Hospitals, Hyderabad, Telangana, India

Oral Corticosteroids' Role in Pediatric Obstructive Sleep Apnea

Not Applicable
Completed
Conditions
Pediatric Obstructive Sleep Apnea
Interventions
Procedure: Adenotonsillectomy
First Posted Date
2025-04-08
Last Posted Date
2025-04-17
Lead Sponsor
Hotel Dieu de France Hospital
Target Recruit Count
87
Registration Number
NCT06917768
Locations
🇱🇧

Hotel Dieu de France, Beirut, Lebanon

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

First Posted Date
2025-03-24
Last Posted Date
2025-05-06
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
594
Registration Number
NCT06890884
Locations
🇮🇱

Haddasah Medical Center ( Site 0601), Jerusalem, Israel

🇮🇱

Sheba Medical Center ( Site 0603), Ramat Gan, Israel

A Study to Prevent Infantile Spasms Relapse

Phase 2
Recruiting
Conditions
Infantile Spasms
Infantile Epileptic Spasms Syndrome
West Syndrome
Interventions
First Posted Date
2025-02-11
Last Posted Date
2025-05-08
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
40
Registration Number
NCT06819670
Locations
🇺🇸

UCLA, Los Angeles, California, United States

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

First Posted Date
2024-12-05
Last Posted Date
2025-05-14
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
1046
Registration Number
NCT06717347
Locations
🇺🇸

Cancer Blood and Specialty Clinic ( Site 0109), Los Alamitos, California, United States

🇺🇸

Cancer Care Specialists of Illinois ( Site 0152), O'Fallon, Illinois, United States

🇺🇸

Fort Wayne Medical Oncology and Hematology ( Site 0149), Fort Wayne, Indiana, United States

and more 120 locations

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

Phase 2
Not yet recruiting
Conditions
IgA Nephropathy (IgAN)
Interventions
First Posted Date
2024-11-06
Last Posted Date
2025-03-27
Lead Sponsor
Mayo Clinic
Target Recruit Count
16
Registration Number
NCT06676579
Locations
🇺🇸

Mayo Clinic in Florida, Jacksonville, Florida, United States

🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis

Phase 4
Not yet recruiting
Conditions
Sarcoidosis
Interventions
First Posted Date
2024-10-23
Last Posted Date
2024-10-23
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Target Recruit Count
100
Registration Number
NCT06654934
Locations
🇮🇳

Post Graduate Institute of Medical Education and Research, Chandigarh, India

© Copyright 2025. All Rights Reserved by MedPath